INVO News and Press, INVO BioScience Inc. From 07/28/23

2023-07-28 08:23:12 ET Reata Pharmaceuticals ( RETA ) +51% agrees to buy Reata Pharmaceuticals in deal valued at $7.3B . SIGA Technologies ( SIGA ) +32% jumps 27% on U.S. government orders worth $138M. Coursera ( COUR ) +17% Q2 earnings call release INV...

2023-07-27 10:10:26 ET INVO Bioscience ( NASDAQ: INVO ) said Thursday it will effect a 1-for-20 reverse split of its common stock. The stock split will be effective as of 12:01 a.m. Eastern Time on July 28, 2023. As a result of the reverse stock split, the CUSIP number for...

INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023 PR Newswire SARASOTA, Fla. , July 27, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expa...

INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device PR Newswire INVOcell now cleared for 5-day incubation period Supporting data reflects improved patient outcomes, similar to IVF SARASOTA, Fla. , June 27, 2023 /PRNe...

2023-06-27 06:08:00 ET 3 Reasons to Day Trade Penny Stocks in 2023 The allure of penny stocks, traditionally defined as securities trading for less than $5 per share, lies in their potential to deliver significant returns with minimal initial investment. Trading penny stocks in 2023 ...

2023-05-15 20:05:24 ET INVO Bioscience, Inc. (INVO) Q1 2023 Results Conference Call May 15, 2023 04:30 PM ET Company Participants Robert Blum - Lytham Partners Steve Shum - CEO Mike Campbell - Chief Operating Officer and VP of Business Development Andrea Gore...

2023-05-15 16:07:41 ET INVO BioScience press release ( NASDAQ: INVO ): Q1 GAAP EPS of -$0.20 misses by $0.04 . Revenue of $0.34M (+112.5% Y/Y) misses by $0.03M . For further details see: INVO BioScience GAAP EPS of -$0.20 misses by $0.04, revenue of $0.34...

INVO Reports First Quarter 2023 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , May 15, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage ferti...

INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , May 8, 2023 /PRNewswire/ -- INVO B...

2023-04-17 19:01:05 ET INVO Bioscience, Inc. (INVO) Q4 2022 Earnings Conference Call April 17, 2023, 4:30 PM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Steven Shum - Chief Executive Officer Andrea Goren - Chief Financial Officer ...